138 related articles for article (PubMed ID: 21595878)
1. Effect of human activated NRAS on replication of delNS1 H5N1 influenza virus in MDCK cells.
Zhu J; Zhou H; Zou W; Jin M
Virol J; 2011 May; 8():240. PubMed ID: 21595878
[TBL] [Abstract][Full Text] [Related]
2. MDCK cell line with inducible allele B NS1 expression propagates delNS1 influenza virus to high titres.
van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ
Vaccine; 2011 Sep; 29(40):6976-85. PubMed ID: 21787829
[TBL] [Abstract][Full Text] [Related]
3. An A14U Substitution in the 3' Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs.
Zheng M; Wang P; Song W; Lau SY; Liu S; Huang X; Mok BW; Liu YC; Chen Y; Yuen KY; Chen H
J Virol; 2015 Oct; 89(20):10273-85. PubMed ID: 26223635
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the M-gene segment can substantially increase replication efficiency of NS1 deletion influenza A virus in MDCK cells.
van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ
J Virol; 2012 Nov; 86(22):12341-50. PubMed ID: 22951840
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.
Nicolodi C; Groiss F; Kiselev O; Wolschek M; Seipelt J; Muster T
Vaccine; 2019 Jun; 37(28):3722-3729. PubMed ID: 31155415
[TBL] [Abstract][Full Text] [Related]
6. A Naturally Occurring Deletion in the Effector Domain of H5N1 Swine Influenza Virus Nonstructural Protein 1 Regulates Viral Fitness and Host Innate Immunity.
Wang J; Zeng Y; Xu S; Yang J; Wang W; Zhong B; Ge J; Yin L; Bu Z; Shu HB; Chen H; Lei CQ; Zhu Q
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563291
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame.
van Rikxoort M; Michaelis M; Wolschek M; Muster T; Egorov A; Seipelt J; Doerr HW; Cinatl J
PLoS One; 2012; 7(5):e36506. PubMed ID: 22563505
[TBL] [Abstract][Full Text] [Related]
8. A genetically engineered influenza A virus with ras-dependent oncolytic properties.
Bergmann M; Romirer I; Sachet M; Fleischhacker R; García-Sastre A; Palese P; Wolff K; Pehamberger H; Jakesz R; Muster T
Cancer Res; 2001 Nov; 61(22):8188-93. PubMed ID: 11719449
[TBL] [Abstract][Full Text] [Related]
9. A Conserved Residue, Tyrosine (Y) 84, in H5N1 Influenza A Virus NS1 Regulates IFN Signaling Responses to Enhance Viral Infection.
Wang BX; Wei L; Kotra LP; Brown EG; Fish EN
Viruses; 2017 May; 9(5):. PubMed ID: 28498306
[TBL] [Abstract][Full Text] [Related]
10. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
11. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.
Wang X; Li M; Zheng H; Muster T; Palese P; Beg AA; García-Sastre A
J Virol; 2000 Dec; 74(24):11566-73. PubMed ID: 11090154
[TBL] [Abstract][Full Text] [Related]
12. Role of TGF-β-activated kinase 1 (TAK1) activation in H5N1 influenza A virus-induced c-Jun terminal kinase activation and virus replication.
Sheng T; Sun Y; Sun J; Prinz RA; Peng D; Liu X; Xu X
Virology; 2019 Nov; 537():263-271. PubMed ID: 31539775
[TBL] [Abstract][Full Text] [Related]
13. Differential Modulation of Innate Immune Responses in Human Primary Cells by Influenza A Viruses Carrying Human or Avian Nonstructural Protein 1.
Monteagudo PL; Muñoz-Moreno R; Fribourg M; Potla U; Mena I; Marjanovic N; Hartmann BM; Sealfon SC; García-Sastre A; Ramos I; Fernández-Sesma A
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597767
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolic mofetil, an alternative antiviral and immunomodulator for the highly pathogenic avian influenza H5N1 virus infection.
Cho J; Yi H; Jang EY; Lee MS; Lee JY; Kang C; Lee CH; Kim K
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):298-304. PubMed ID: 29017920
[TBL] [Abstract][Full Text] [Related]
15. The Ebola virus VP35 protein functions as a type I IFN antagonist.
Basler CF; Wang X; Mühlberger E; Volchkov V; Paragas J; Klenk HD; García-Sastre A; Palese P
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12289-94. PubMed ID: 11027311
[TBL] [Abstract][Full Text] [Related]
16. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
[TBL] [Abstract][Full Text] [Related]
17. The role of nuclear NS1 protein in highly pathogenic H5N1 influenza viruses.
Mok BW; Liu H; Chen P; Liu S; Lau SY; Huang X; Liu YC; Wang P; Yuen KY; Chen H
Microbes Infect; 2017 Dec; 19(12):587-596. PubMed ID: 28903072
[TBL] [Abstract][Full Text] [Related]
18. Effect on virulence and pathogenicity of H5N1 influenza A virus through truncations of NS1 eIF4GI binding domain.
Zhou H; Zhu J; Tu J; Zou W; Hu Y; Yu Z; Yin W; Li Y; Zhang A; Wu Y; Yu Z; Chen H; Jin M
J Infect Dis; 2010 Nov; 202(9):1338-46. PubMed ID: 20854176
[TBL] [Abstract][Full Text] [Related]
19. Differences in Type I interferon response in human lung epithelial cells infected by highly pathogenic H5N1 and low pathogenic H11N1 avian influenza viruses.
Thube MM; Shil P; Kasbe R; Patil AA; Pawar SD; Mullick J
Virus Genes; 2018 Jun; 54(3):414-423. PubMed ID: 29574656
[TBL] [Abstract][Full Text] [Related]
20. Inability of NS1 protein from an H5N1 influenza virus to activate PI3K/Akt signaling pathway correlates to the enhanced virus replication upon PI3K inhibition.
Li W; Wang G; Zhang H; Shen Y; Dai J; Wu L; Zhou J; Jiang Z; Li K
Vet Res; 2012 Apr; 43(1):36. PubMed ID: 22530768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
